Benzinga | Nov 23, 2021 07:14AM EST

Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Lowers Price Target to $12

Raymond James analyst John Ransom maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Strong Buy and lowers the price target from $15 to $12.